The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy
- Nananda F. Col, MD, MPP, MPH; and
- Stephen G. Pauker, MD
- From Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120; and Tufts-New England Medical Center, Boston, MA 02111.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
Despite mounting evidence concerning the risks of hormone therapy, the NHS authors still believe that it is cardioprotective if initiated in newly menopausal …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
